Analystreport

BridgeBio Pharma, Inc. (NASDAQ: BBIO) had its price target raised by analysts at Mizuho from $23.00 to $29.00.

BridgeBio Pharma, Inc.  (BBIO) 
Last bridgebio pharma, inc. earnings: 3/2 08:29 am Check Earnings Report